skip to Main Content

History

The path of ASTERASYS

2020

March
Acquisition of ISO 13485: 2016 DNV CE for Futera Dots
Acquisition of KC Certification for Aqua Peel
May
Acquisition of KFDA for Futera Dots
Acquisition of Brazil’s INMETRO and ANVISA for Liftera-A / Liftera-V
June
Acquisition of KFDA for 10THERA

2019

January
Transferred the headquarters to Seongsu-dong, Seongdong-gu, Seoul Metropolitan City
March
Transferred the factory (factory in Seongsu-dong)
May
Launched a specialized aesthetic brand, Bellerev
Launched the economical cosmetics brand, Dr. Seolleim
June
Venture Company confirmation
August
Launched products including Belle-Up, Belle-Clean, Belle-Shine and Belle-Mix
September
Launched a new product, Liftera-A
October
Acquisition of certification for ISO 13485: 2016 MTIC CE change
December
Received $5 Million Export Tower
Acquisition of certification for KFDA GMP change

2018

January
Changed the company name to ASTERASYS
March
Acquisition of China’s CVC Certification for Liftera-V
April
Acquisition of an export license for AquaPeel Tera
May
Acquisition of an export license for Futera Dots
Acquisition of an export license for RF Tera
June
Establishment of an R&D Institute
August
Acquisition of CE Certification for Liftera-A (Medical Device (MD) Mark labeling)
October
Acquisition of ISO13485 Certification for medical device
November
Secured an investment of 4 billion Won from Premier Partners Ltd.

2017

January
Obtained permission to export license for Liftera-V
February
Launched Pen Applicator (TDT Technology)
March
HIFU PLUS certified and approved by KFDA

2016

January
KGMP Acquisition
February
Certified by ISO13485
March
Liftera-A certified for domestic and export licenses
June
Launched Liftera-P in Korea and obtained permission for export license
July
Launched InBalance 300 in Korea and obtained permission for export license

2015

July
Establishment of DAIHAN Biomedical Co., Ltd.
Back To Top